The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Effects of a Dopamine Agonist Piribedil in Depressed Patients: Relationship of Pretreatment Homovanillic Acid to Antidepressant Response
Abstract
Piribedil, a compound that stimulates dopamine receptors in a relatively specific fashion, was administered to 11 hospitalized depressed patients. The dopamine agonist significantly decreased rapid eye movement (REM) sleep and percent REM sleep and increased REM latency. Piribedil decreased the probenecid-induced accumulation of the dopamine metabolite homovanillic acid (HVA) in CSF. A range of mild to moderate antidepressant effects was noted; one patient worsened and one developed recurrent manic episodes. The degree of improvement in depression was negatively correlated with pretreatment values of HVA in CSF (r = -.66, P less than .05). These data suggest that the heterogeneity of clinical response may be related to biological differences in depressed patients and that those with low initial dopaminergic function respond best to increased dopamine receptor stimulation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other examples of DA agents effective in the treatment of MDD include the selective D2/D3 receptor agonists pramipexole [292] and piribedil [293] the catechol-O-methyltransferase inhibitor tolcapone, [294], and the preferential presynaptic DA antagonist amisulpride, [295].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [293]
Citations
Cites
Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 27,137
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 11,772
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Development of a Rating Scale for Primary Depressive Illness
Hamilton, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
Schildkraut, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,568
Norepinephrine in Depressive Reactions
Bunney, W. E. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01730060001001 · Cited by 1,166
"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?
Åsberg, M., Thorén, P., Traskman, L., Bertilsson, L., & Ringberger, V. (1976) · Science · doi:10.1126/science.1246632 · Cited by 682
Methods for Reliable Longitudinal Observation of Behavior
Bunney, W. E. (1963) · Archives of General Psychiatry · doi:10.1001/archpsyc.1963.01720150090010 · Cited by 480
REM latency: a psychobiologic marker for primary depressive disease.
Dj, K. (1976) · PubMed · Cited by 443
Clinical criteria for psychiatric diagnosis and DSM-III
Spitzer, R. L., Endicott, J., & Robins, E. (1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.11.1187 · Cited by 402
Jones, B. E., Harper, S. T., & Halaris, A. E. (1977) · Brain Research · doi:10.1016/0006-8993(77)90948-9 · Cited by 281
Cerebrospinal Fluid Amine Metabolites in Affective Illness: The Probenecid Technique
Goodwin, F. K., Post, R. M., Dünner, D. L., & Gordon, E. K. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.1.73 · Cited by 244
Self-citationÅsberg, M., Bertilsson, L., Tuck, D., Cronholm, B., & Sjöqvist, F. (1973) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1973142277 · Cited by 242
van Kammen, D. P., & Murphy, D. L. (1975) · Psychopharmacology · doi:10.1007/bf00428897 · Cited by 237
REM Sleep Reduction Effects on Depression Syndromes
Vogel, G. W. (1975) · Archives of General Psychiatry · doi:10.1001/archpsyc.1975.01760240093007 · Cited by 213
Monoamine metabolites in lumbar CSF: The question of their origin in relation to clinical studies
Garelis, E., Young, S. N., Lal, S., & Sourkes, T. L. (1974) · Brain Research · doi:10.1016/0006-8993(74)90562-9 · Cited by 189
Depression in Patients with Parkinsonism
Robins, A. H. (1976) · The British Journal of Psychiatry · doi:10.1192/bjp.128.2.141 · Cited by 185
L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients.
Fk, G., Dl, M., Brodie, H. K. H., & Bunney, W. E. (1970) · PubMed · Cited by 182
Unipolar and Bipolar Affective Illness
Beigel, A. (1971) · Archives of General Psychiatry · doi:10.1001/archpsyc.1971.01750090021003 · Cited by 178
ET495 and brain catecholamine mechanisms: Evidence for stimulation of dopamine receptors
CORRODI, H., Farnebo, L., Fuxé, K., Hamberger, B., & Ungerstedt, U. (1972) · European Journal of Pharmacology · doi:10.1016/0014-2999(72)90149-5 · Cited by 176
Research design in clinical psychology and psychiatry
Chassan, J. B. (1967) · Andalas University Repository (Andalas University) · Cited by 170
Mendelson, W. B., Gillin, J. C., & Wyatt, R. J. (1977) · Springer eBooks · doi:10.1007/978-1-4684-2289-4 · Cited by 149
A dopaminergic mechanism in mania
Gerner, R. H., Post, R. M., & Bunney, W. E. (1976) · American Journal of Psychiatry · doi:10.1176/ajp.133.10.1177 · Cited by 144
Self-citationVanpraag, H. (1977) · PubMed · Cited by 135
Behavioral effects of l-Dopa in schizophrenic patients
ANGRIST, B. M., Sathananthan, G., & Gershon, S. (1973) · Psychopharmacology · doi:10.1007/bf00429294 · Cited by 119
Amine Metabolites in Human Cerebrospinal Fluid: Effects of Cord Transection and Spinal Fluid Block
Post, R. M., Goodwin, F. K., Gordon, E. K., & Watkin, D. M. (1973) · Science · doi:10.1126/science.179.4076.897 · Cited by 115
Self-citationAmine Precursors and Depression
MENDELS, J. (1975) · Archives of General Psychiatry · doi:10.1001/archpsyc.1975.01760190024002 · Cited by 112
Effect of Lithium on Brain Dopamine
Friedman, E., & Gershon, S. (1973) · Nature · doi:10.1038/243520a0 · Cited by 98
Morgenroth, V. H., Walters, J. R., & Roth, R. H. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90240-9 · Cited by 98
Rapid Eye Movement Sleep Density
FOSTER, F. G. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770090109011 · Cited by 98
Goldstein, M., Battista, A. F., Ohmoto, T., ANAGNOSTE, B., & Fuxé, K. (1973) · Science · doi:10.1126/science.179.4075.816 · Cited by 96
Bowers, M. B. (1972) · Neuropharmacology · doi:10.1016/0028-3908(72)90061-5 · Cited by 95
Walters, Bs, B., & Rh, R. (1975) · PubMed · Cited by 89
Effects of low doses of catecholamine receptor agonists on exploration in mice
Strömbom, U. (1975) · Journal of Neural Transmission · doi:10.1007/bf01670131 · Cited by 86
Curzon, G., Gumpert, E. J. W., & SHARPE, D. M. (1971) · Nature New Biology · doi:10.1038/newbio231189a0 · Cited by 81
Monoamine precursors in the treatment of depression
Carroll, B. J. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1971125743 · Cited by 73
On the origin of homovanillic acid (HVA) in the cerebrospinal fluid
Sourkes, T. L. (1973) · Journal of Neural Transmission · doi:10.1007/bf01244668 · Cited by 69
Imipramine and Desipramine in Plasma and Spinal Fluid
Muscettola, G. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770290103009 · Cited by 66
Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis.
Goodwin, F. K., & Post, R. M. (1975) · PubMed · Cited by 64
Self-citationREM inhibitory effect of L-dopa infusion during human sleep
Gillin, J. C., Post, R. M., Wyatt, R. J., Goodwin, F. K., Snyder, F. R., & Bunney, W. E. (1973) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(73)90174-0 · Cited by 60
Self-citationAlterations in behaviour and catecholamine biosynthesis induced by lithium
Segal, D. S., CALLAGHAN, M., & Mandell, A. J. (1975) · Nature · doi:10.1038/254058a0 · Cited by 56
Approaches to Brain Amines in Psychiatric Patients: A Reevaluation of Cerebrospinal Fluid Studies
Post, R. M., & Goodwin, F. K. (1978) · Springer eBooks · doi:10.1007/978-1-4684-3189-6_3 · Cited by 54
Self-citationClinical studies with dopamine-receptor stimulants
ANGRIST, B. M., Thompson, H., Shopsin, B., & Gershon, S. (1975) · Psychopharmacology · doi:10.1007/bf00428906 · Cited by 53
The effect of orally administered cocaine on sleep of depressed patients
Post, R. M., Gillin, J. C., Wyatt, R. J., & Goodwin, F. K. (1974) · Psychopharmacology · doi:10.1007/bf00426683 · Cited by 50
Self-citationBehavioural evidence of dopamine receptor stimulation by piribedil (ET495) and its metabolite S584
Creese, I. (1974) · European Journal of Pharmacology · doi:10.1016/0014-2999(74)90111-3 · Cited by 49
THE EFFECTS OF LITHIUM ON NOREPINEPHRINE TURNOVER AND METABOLISM: BASIC AND CLINICAL STUDIES
Schildkraut, J. J. (1974) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197405000-00006 · Cited by 46
Parkinson Disease Treated With a Suspected Dopamine Receptor Agonist
Chase, T. N., Woods, A. C., & Glaubiger, G. A. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490350041006 · Cited by 43
Central Monoamine Deficiency in Depressions: Causative or Secondary Phenomenon?*
Praag, H. M. V., & Korf, J. (1975) · Pharmacopsychiatry · doi:10.1055/s-0028-1094463 · Cited by 41
Apomorphine and psychopathology.
Lal, S., & VEGA, C. E. D. L. (1975) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.38.7.722 · Cited by 39
Apomorphine and piribedil in rats: biochemical and pharmacologic studies.
Rf, B., Jc, P., & Barbeau, A. (1975) · PubMed · Cited by 39
EFFECTS OF LOW DOSES OF A DOPAMINE-RECEPTOR STIMULATOR IN MANIA
Post, R. M., Gerner, R. H., Carman, J., & Bunney, W. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91319-2 · Cited by 35
Self-citationPiribedil, a dopamine agonist, in Parkinson's disease
Sweet, R. D., Wasterlain, C. G., & MCDOWELL, F. H. (1974) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt19741661077 · Cited by 31
Affective disorder: studies with amine precursors
Dünner, D. L., & Fieve, R. R. (1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.2.180 · Cited by 30
Effects of piribedil on noradrenaline and MOPEG-SO4 levels in the rat brain
Garattini, S. K., Bareggi, S. R., Marc, V., Calderini, G., & Morselli, P. L. (1974) · European Journal of Pharmacology · doi:10.1016/0014-2999(74)90134-4 · Cited by 25
Psychotropic drugs and dopamine uptake inhibition.
Halaris, A. E., & Dx, F. (1975) · PubMed · Cited by 21
Dopaminergic mechanisms in patients with extrapyramidal disease.
Chase, T. N., & Shoulson, I. (1975) · PubMed · Cited by 21
Indications of piribedil in L-DOPA-treated parkinsonian patients: physiopathologic implications.
Rondot, P., Bathien, N., & Jl, D. (1975) · PubMed · Cited by 21
Jori, A., Cecchetti, G., Dolfini, E., Monti, E., & Garattini, S. K. (1974) · European Journal of Pharmacology · doi:10.1016/0014-2999(74)90152-6 · Cited by 20
Homovanillic acid transport by the spinal cord
Kessler, J. A., Fenstermacher, J. D., & Patlak, C. S. (1976) · Neurology · doi:10.1212/wnl.26.5.434 · Cited by 18
Cardiovascular effects of the 1-(2″ pyrimidyl)-4 piperonyl piperazine (ET 495)
Laubie, M., Schmitt, H., & Douarec, J. C. L. (1969) · European Journal of Pharmacology · doi:10.1016/0014-2999(69)90200-3 · Cited by 17
FEIGENSON, J. S., Sweet, R. D., & MCDOWELL, F. H. (1976) · Neurology · doi:10.1212/wnl.26.5.430 · Cited by 13
Dopamine receptor agonists in psychiatric disease.
Arbuthnott, G. W., & Lg, M. (1975) · PubMed · Cited by 12
Studies on piribedil in Parkinsonism.
Lieberman, A. N., Shopsin, B., Yl, B., Boal, D., & Zolfaghari, M. (1975) · PubMed · Cited by 11
The influence of piribedil (ET495) on components of locomotor activity
Jenner, P. G., & MARSDEN, C. D. (1975) · European Journal of Pharmacology · doi:10.1016/0014-2999(75)90160-0 · Cited by 7
Clinical studies of dopaminergic mechanisms.
Chase, T. N. (1974) · PubMed · Cited by 6
Cited by
Sorted by citations
The role of dopamine in the pathophysiology of depression
Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244
What Is a “Mood Stabilizer”? An Evidence-Based Response
Bauer, M. S., & Mitchner, L. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.3 · Cited by 865
Swerdlow, N. R., & Koob, G. F. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047488 · Cited by 674
Cerebral Metabolic Rates for Glucose in Mood Disorders
Baxter, L. R. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790280019002 · Cited by 602
Magnetic Resonance Imaging of the Caudate Nuclei in Depression: Preliminary Observations
Krishnan, K. R. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820070047007 · Cited by 365
Metadata
- Authors
- Post, R. M.
- Corresponding author
- Post, Robert M.
- ORCID
- Post, Robert M.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1978-05-01
- Volume
- 35
- Issue
- 5
- Pages
- 609
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W1981234468
- Cited by
- 168
- References
- 65
- Citations by year
- 2023: 1 · 2022: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2016: 3 · 2015: 3 · 2014: 2 · 2013: 1 · 2012: 4
- FWCI
- 7.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- piribedil, dopamine agonists, depression, REM sleep, REM latency, homovanillic acid, cerebrospinal fluid, probenecid, antidepressant response, manic episodes, dopaminergic activity, individual differences in treatment response
- MeSH terms
- Adult, Bipolar Disorder, Clinical Trials as Topic, Depression, Double-Blind Method, Female, Homovanillic Acid, Humans, Male, Middle Aged, Phenylacetates, Piperazines, Piribedil, Psychiatric Status Rating Scales, Receptors, Dopamine, Sleep, REM
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review